You need to upgrade your Flash Player
|
Volume 1, Number 9
With information from the latest evidence-based studies, participants should be able to:
- Describe the association between subpopulations of triglyceride-rich and high-density lipoproteins adn the extent of coronary heart disease in postmenopausal women
- Characterize the long-term benefits of bezafibrate therapy in the secondary prevention of cardiovascular events among patients with coronary heart disease and dyslipidemia
- Delineate the impact of informing patients of their calculated coronary risk on the effectiveness of statin therapy
Click here to listen to this podcast. (Or, to download the audio file, right click on the link and choose "Save Target As".)
Subscribe to the Clinical Insights® in Lipid Management Podcast.
To subscribe, copy and paste, or drag, the above RSS icon into your "podcatcher"
software (for example, iTunes or iPodder).
Volume 1, Number 8
With information from the latest evidence-based studies, participants should be able to:
- Discuss the benefits of pravastatin therapy in women with hypercholesterolemia
- Describe the association between socioeconomic position and inflammatory burden among different race/ethnic groups
- Identify the age-specific associations of total cholesterol with ischemic heart disease, stroke, and other vascular mortality
Click here to listen to this podcast. (Or, to download the audio file, right click on the link and choose "Save Target As".)
Subscribe to the Clinical Insights® in Lipid Management Podcast.
To subscribe, copy and paste, or drag, the above RSS icon into your "podcatcher"
software (for example, iTunes or iPodder).
Volume 1, Number 7
With information from the latest evidence-based studies, participants should be able to:
- Assess the link of Crohn's disease to atherogenesis and high-density lipoprotein (HDL)
- Outline the effects of fenofibrate and simvastatin on HDL-related biomarkers in patients with low HDL
- Describe the suppressive effects of diacylgycerol oil on postprandial hyperlipidemia in patients with insulin resistance and glucose intolerance
Click here to listen to this podcast. (Or, to download the audio file, right click on the link and choose "Save Target As".)
Subscribe to the Clinical Insights® in Lipid Management Podcast.
To subscribe, copy and paste, or drag, the above RSS icon into your "podcatcher"
software (for example, iTunes or iPodder).
Volume 1, Number 6
With information from the latest evidence-based studies, participants should be able to:
- Describe at least one potential mechanism to explain the increased morbidity and mortality observed with use of the CETP inhibitor torcetrapib
- Relate the importance of continuation of statin treatment as a means to reduce the risk of future cardiovascular events and to underscore patient adherence
- Discuss the association between total cholesterol levels and stroke mortality
Click here to listen to this podcast. (Or, to download the audio file, right click on the link and choose "Save Target As".)
Subscribe to the Clinical Insights® in Lipid Management Podcast.
To subscribe, copy and paste, or drag, the above RSS icon into your "podcatcher"
software (for example, iTunes or iPodder).
Volume 1, Number 5
With information from the latest evidence-based studies, participants should be able to:
- Recognize the association between fasting TG level changes over time and CHD risk in young adults
- Identify the development of minor strokes with increased total serum cholesterol levels
- Compare the effectiveness of two statins on CRP (<2 mg/L) and LDL-C (<70 mg/dL) among patients with type 2 diabetes
Click here to listen to this podcast. (Or, to download the audio file, right click on the link and choose "Save Target As".)
Subscribe to the Clinical Insights® in Lipid Management Podcast.
To subscribe, copy and paste, or drag, the above RSS icon into your "podcatcher"
software (for example, iTunes or iPodder).
Volume 1, Number 4
With information from the latest evidence-based studies, participants should be able to:
- Identify the atherogenic qualities of the lipoprotein(a) molecule [Lp(a)]
- Recognize the predictive value of HDL-C levels for major CV events, even when LDL-C levels are below 70 mg/dL
- Characterize follow-up statin safety and efficacy data after the end of a landmark lipid-lowering study
Click here to listen to this podcast. (Or, to download the audio file, right click on the link and choose "Save Target As".)
Subscribe to the Clinical Insights® in Lipid Management Podcast.
To subscribe, copy and paste, or drag, the above RSS icon into your "podcatcher"
software (for example, iTunes or iPodder).
Volume 1, Number 3
With information from the latest evidence-based studies, participants should be able to:
- Ascertain whether statin-associated adverse events are proportional to LDL-C reduction
- Evaluate the efficacy and safety of long-term statin therapy in children with familial hypercholesterolemia, as well as the relation between the age of statin initiation and carotid IMT
- Characterize no evidence of interaction observed between clopidogrel and type of statins when administered concomitantly to high-risk patients
Click here to listen to this podcast. (Or, to download the audio file, right click on the link and choose "Save Target As".)
Subscribe to the Clinical Insights® in Lipid Management Podcast. To subscribe, copy and paste, or drag, the above RSS icon into your "podcatcher" software (for example, iTunes or iPodder).
Volume 1, Number 2
With information from the latest evidence-based studies, participants should be able to:
- Recognize the impact of the Mediterranean diet on cellular lipid levels and LDL oxidation in patients at high cariovascular risk
- Explain the increase in cardiovascular risk associated with increasing postprandial trigylceride levels
- Describe the effect of statin use in individuals with very low LDL-C levels (<60 mg/dL)
Click here to listen to this podcast. (Or, to download the audio file, right click on the link and choose "Save Target As".)
Subscribe to the Clinical Insights® in Lipid Management Podcast. To subscribe, copy and paste, or drag, the above RSS icon into your "podcatcher" software (for example, iTunes or iPodder).
Volume 1, Number 1
With information from the latest evidence-based studies, participants should be able to:
- Detail the anti-inflammatory effects of combination lipid-lowering therapies incorporating different mechanisms of action
- Recognize the worsened prognosis for patients with preexisting atherosclerosis who have the metabolic syndrome
- Identify the gap in treatment for patients at presumptive high cardiovascular risk (ie, in chest pain units)
Click here to listen to this podcast. (Or, to download the audio file, right click on the link and choose "Save Target As".)
Subscribe to the Clinical Insights® in Lipid Management Podcast. To subscribe, copy and paste, or drag, the above RSS icon into your "podcatcher" software (for example, iTunes or iPodder).
|